These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34420244)

  • 1. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
    Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in Noninvasive Surveillance for Acute Rejection in Pediatric Heart Transplant Recipients: A Real-World Analysis of Donor-Derived Cell-Free DNA-Based Surveillance Protocol.
    Akabas L; Bravo SA; Zhang Y; Simonelli A; Zuckerman WA; Richmond ME; Lytrivi ID
    Clin Transplant; 2024 Oct; 38(10):e15481. PubMed ID: 39412485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ Transplants.
    Moeller CM; Oren D; Fernandez Valledor A; Rubinstein G; Lotan D; Mehlman Y; Slomovich S; Rahman S; Lee C; Baranowska J; Regan M; Elad B; DeFilippis EM; Hennecken C; Salazar R; Raikhelkar J; Clerkin KJ; Fried J; Lin E; Bae D; Oh KT; Latif F; Topkara VK; Naka Y; Takeda K; Majure D; Uriel N; Sayer G
    Clin Transplant; 2024 Oct; 38(10):e15479. PubMed ID: 39422086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Miller SA; Zinn MD
    Clin Transplant; 2023 May; 37(5):e14933. PubMed ID: 36779524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation.
    Richmond ME; Zangwill SD; Kindel SJ; Deshpande SR; Schroder JN; Bichell DP; Knecht KR; Mahle WT; Wigger MA; Gaglianello NA; Pahl E; Simpson PM; Dasgupta M; North PE; Hidestrand M; Tomita-Mitchell A; Mitchell ME
    J Heart Lung Transplant; 2020 May; 39(5):454-463. PubMed ID: 31983667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).
    DeFilippis EM; Sweigart B; Khush KK; Shah P; Agbor-Enoh S; Valantine HA; Vest AR
    J Heart Lung Transplant; 2024 Jul; 43(7):1135-1141. PubMed ID: 38460620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
    Kim PJ; Olymbios M; Siu A; Wever Pinzon O; Adler E; Liang N; Swenerton R; Sternberg J; Kaur N; Ahmed E; Chen YA; Fehringer G; Demko ZP; Billings PR; Stehlik J
    J Heart Lung Transplant; 2022 Jul; 41(7):919-927. PubMed ID: 35577713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Plasma Donor-derived Cell-free DNA to Gene Expression in Endomyocardial Biopsies in the Trifecta-Heart Study.
    Halloran PF; Reeve J; Mackova M; Madill-Thomsen KS; Demko Z; Olymbios M; Campbell P; Melenovsky V; Gong T; Hall S; Stehlik J
    Transplantation; 2024 Sep; 108(9):1931-1942. PubMed ID: 38538559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center utilization of donor-derived cell-free DNA testing in the management of heart transplant patients.
    Gondi KT; Kao A; Linard J; Austin BA; Everley MP; Fendler TJ; Khumri T; Lawhorn SL; Magalski A; Nassif ME; Sperry BW; Vodnala D; Borkon AM
    Clin Transplant; 2021 May; 35(5):e14258. PubMed ID: 33606316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local laboratory-run donor-derived cell-free DNA assay for rejection surveillance in heart transplantation-first six months of clinical experience.
    Teszak T; Bödör C; Hegyi L; Levay L; Nagy B; Fintha A; Merkely B; Sax B
    Clin Transplant; 2023 Sep; 37(9):e15078. PubMed ID: 37489087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of noninvasive surveillance for allograft rejection in heart transplant patients > 1 year after transplant.
    Kewcharoen J; Kim J; Cummings MB; Leitner KB; Suzuki EMB; Banerjee D; Lum CJ
    Clin Transplant; 2022 Mar; 36(3):e14548. PubMed ID: 34843112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators.
    Mehta A; Goldberg J; Bagchi P; Marboe C; Shah KB; Najjar SS; Hsu S; Rodrigo ME; Jang MK; Cochrane A; Tchoukina IF; Kong H; Lohmar BJ; Mcnair E; Valantine HA; Agbor-Enoh S; Berry GJ; Shah P
    J Heart Lung Transplant; 2024 Oct; ():. PubMed ID: 39424014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Association Between Donor-Derived Cell-Free DNA and Cardiac Allograft Vasculopathy.
    Alharethi R; Knight S; Luikart HI; Wolf-Doty T; Bride DL; Kim DT; Khush KK
    Clin Transplant; 2024 Jul; 38(7):e15416. PubMed ID: 39058520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endomyocardial biopsy in pediatric heart transplant recipients: a useful exercise? (Analysis of 1,169 biopsies).
    Wagner K; Oliver MC; Boyle GJ; Miller SA; Law YM; Pigula F; Webber SA
    Pediatr Transplant; 2000 Aug; 4(3):186-92. PubMed ID: 10933318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-derived cell-free DNA predicted allograft rejection and severe microvascular inflammation in kidney transplant recipients.
    Kim HD; Bae H; Kang H; Lee H; Eum SH; Yang CW; Choi YJ; Chung BH; Oh EJ
    Front Immunol; 2024; 15():1433918. PubMed ID: 39044817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant.
    Bromberg JS; Bunnapradist S; Samaniego-Picota M; Anand S; Stites E; Gauthier P; Demko Z; Prewett A; Armer-Cabral M; Marshall K; Kaur N; Bloom MS; Tabriziani H; Bhorade S; Cooper M;
    Transplantation; 2024 Sep; 108(9):1994-2004. PubMed ID: 38595232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.